University Of MissouriEcho Global Granger Management Mercy HealthFox Chase Cancer CenterEclipse VenturesMayo ClinicGE HealthcareAstra Zeneca
Description
Nucleus RadioPharma announced the closing of a Series A extension round with new investor AstraZeneca, joining existing investors GE Healthcare, Mayo Clinic, and others. The funding will be used to expand development, supply, and commercial manufacturing capabilities to make targeted radiotherapies and theranostics more accessible to patients globally.
Who to call at Nucleus RadioPharma, and when
A new round usually means Nucleus RadioPharma is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Nucleus RadioPharma raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Nucleus RadioPharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nucleus RadioPharma. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Nucleus RadioPharma
Location
Davidson, North Carolina, United States
About
Nucleus RadioPharma is an innovative CDMO dedicated to the development and manufacturing of targeted radiotherapies. With an emphasis on innovation and quality, Nucleus provides an array of services, from formulation and analytical development to regulatory documentation and drug product manufacturing. Its technology platforms are at the forefront of radiopharmaceutical research, designed to advance new therapies through clinical trials to commercialization.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nucleus RadioPharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
DavidsonManufacturingBiotechnologyHealth Carepharmaceuticals